Sun Pharma to acquire Organon in USD 11.75 billion deal
Sun Pharma→Organon
Apr 28, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
IMG Pharma has entered into a definitive agreement to acquire Matsumoto Pharmaceutical, a pharmacy business in Japan. IMG Pharma acquisitions focus on expanding healthcare distribution and retail pharmacy capabilities, while Matsumoto Pharmaceutical operates in Japan’s pharmaceutical supply and pharmacy market. The IMG Pharma acquisitions are positioned as a strategic acquisition to strengthen presence in the Japanese pharmacy sector and support long-term growth in healthcare M&A. The merger acquisition is announced and structured as a strategic acquisition, with deal size undisclosed and completion subject to customary closing conditions.
Filed under
Source
Read full article on prnewswire.comvia GN - entered into definitive agreement · April 27, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
Apr 28, 2026
Sun Pharma→Organon
Apr 28, 2026
TPG→Optum UK
Apr 27, 2026
Sun Pharma→Organon
Apr 27, 2026
Sun Pharma→Organon
Apr 27, 2026